Benefit of additional screening for progressive multifocal leukoencephalopathy in patients with multiple sclerosis taking natalizumab: a decision analysis. Landy DC, Hecht EM Clin Neuropharmacol. 2014 Mar-Apr; 37(2):45-51. PMID: 24614671. Abstract CommentRecommendBookmarkWatch